Arvinas Appoints Dr. John Houston as President and Chief Executive Officer

NEW HAVEN, Conn., Sept. 20, 2017 -- (Healthcare Sales & Marketing Network) -- Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, today announced the appointment of John Houston, Ph.D., as president and... Biopharmaceuticals, Personnel Arvinas, PROteolysis TArgeting Chimeras
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news